中华皮肤科杂志 ›› 2021, Vol. 54 ›› Issue (11): 1019-1022.doi: 10.35541/cjd.20200152
王晓宇 张春雷 王文慧
收稿日期:2020-02-22
修回日期:2021-01-06
发布日期:2021-11-01
通讯作者:
王文慧
E-mail:wwh0608@126.com
基金资助:Wang Xiaoyu, Zhang Chunlei, Wang Wenhui
Received:2020-02-22
Revised:2021-01-06
Published:2021-11-01
Contact:
Wang Wenhui
E-mail:wwh0608@126.com
Supported by:摘要： 【摘要】 间充质干细胞是干细胞家族的重要成员，具有自我更新、多向分化潜能和免疫调节作用及低免疫原性等特点。有文献报告间充质干细胞用于治疗银屑病获得不同程度的疗效，且有较长的疾病缓解期。本文综述间充质干细胞在银屑病中的应用及相关研究进展。
王晓宇 张春雷 王文慧. 间充质干细胞在银屑病中的应用[J]. 中华皮肤科杂志, 2021,54(11):1019-1022. doi:10.35541/cjd.20200152
Wang Xiaoyu, Zhang Chunlei, Wang Wenhui. Application of mesenchymal stem cells in psoriasis[J]. Chinese Journal of Dermatology, 2021, 54(11): 1019-1022.doi:10.35541/cjd.20200152
| ［1］ | Mushahary D, Spittler A, Kasper C, et al. Isolation, cultivation, and characterization of human mesenchymal stem cells［J］. Cytometry A, 2018,93（1）:19⁃31. doi: 10.1002/cyto.a.23242. |
| ［2］ | Chaudhary D, Trivedi RN, Kathuria A, et al. In vitro and In vivo immunomodulating properties of mesenchymal stem cells［J］. Recent Pat Inflamm Allergy Drug Discov, 2018,12（1）:59⁃68. doi: 10.2174/1872213X12666180227105924. |
| ［3］ | Friedenstein AJ, Petrakova KV, Kurolesova AI, et al. Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues［J］. Transplantation, 1968,6（2）:230⁃247. |
| ［4］ | Andrzejewska A, Lukomska B, Janowski M. Concise review: mesenchymal stem cells: from roots to boost［J］. Stem Cells, 2019,37（7）:855⁃864. doi: 10.1002/stem.3016. |
| ［5］ | Campanati A, Consales V, Orciani M, et al. Role of mesenchymal stem cells in the pathogenesis of psoriasis: current perspectives［J］. Psoriasis （Auckl）, 2017,7:73⁃85. doi: 10.2147/PTT.S108311. |
| ［6］ | Wang Q, Yang Q, Wang Z, et al. Comparative analysis of human mesenchymal stem cells from fetal⁃bone marrow, adipose tissue, and Warton′s jelly as sources of cell immunomodulatory therapy［J］. Hum Vaccin Immunother, 2016,12（1）:85⁃96. doi: 10.1080/21645515.2015.1030549. |
| ［7］ | Bougioukli S, Saitta B, Sugiyama O, et al. Lentiviral gene therapy for bone repair using human umbilical cord blood⁃derived mesenchymal stem cells［J］. Hum Gene Ther, 2019,30（7）:906⁃917. doi: 10.1089/hum.2018.054. |
| ［8］ | Damia E, Chicharro D, Lopez S, et al. Adipose⁃derived mesenchymal stem cells: are they a good therapeutic strategy for osteoarthritis?［J］. Int J Mol Sci, 2018,19（7）:1926. doi: 10.3390/ijms19071926. |
| ［9］ | Kern S, Eichler H, Stoeve J, et al. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue［J］. Stem Cells, 2006,24（5）:1294⁃1301. doi: 10.1634/stemcells.2005⁃0342. |
| ［10］ | Ayala⁃Cuellar AP, Kang JH, Jeung EB, et al. Roles of mesenchymal stem cells in tissue regeneration and immunomodulation［J］. Biomol Ther （Seoul）, 2019,27（1）:25⁃33. doi: 10.4062/biomolther.2017.260. |
| ［11］ | 韩齐心, 牛旭平, 刘佳, 等. 间充质干细胞及其外泌体与Th17/Treg对银屑病发病机制的研究进展［J］. 中华皮肤科杂志, 2020,53（2）:151⁃154. doi: 10.35541/cjd.20190012. |
| ［12］ | Wang Y, Tian M, Wang F, et al. Understanding the immunological mechanisms of mesenchymal stem cells in allogeneic transplantation: from the aspect of major histocompatibility complex class I［J］. Stem Cells Dev, 2019,28（17）:1141⁃1150. doi: 10.1089/scd.2018.0256. |
| ［13］ | Bonfield TL, Nolan Koloze MT, Lennon DP, et al. Defining human mesenchymal stem cell efficacy in vivo［J］. J Inflamm （Lond）, 2010,7:51. doi: 10.1186/1476⁃9255⁃7⁃51. |
| ［14］ | Sah SK, Park KH, Yun CO, et al. Effects of human mesenchymal stem cells transduced with superoxide dismutase on imiquimod⁃induced psoriasis⁃like skin inflammation in mice［J］. Antioxid Redox Signal, 2016,24（5）:233⁃248. doi: 10.1089/ars.2015.6368. |
| ［15］ | Lee YS, Sah SK, Lee JH, et al. Human umbilical cord blood⁃derived mesenchymal stem cells ameliorate psoriasis⁃like skin inflammation in mice［J］. Biochem Biophys Rep, 2017,9:281⁃288. doi: 10.1016/j.bbrep.2016.10.002. |
| ［16］ | Kim JY, Park M, Kim YH, et al. Tonsil⁃derived mesenchymal stem cells （T⁃MSCs） prevent Th17⁃mediated autoimmune response via regulation of the programmed death⁃1/programmed death ligand⁃1 （PD⁃1/PD⁃L1） pathway［J］. J Tissue Eng Regen Med, 2018,12（2）:e1022⁃e1033. doi: 10.1002/term.2423. |
| ［17］ | Imai Y, Yamahara K, Hamada A, et al. Human amnion⁃derived mesenchymal stem cells ameliorate imiquimod⁃induced psoriasiform dermatitis in mice［J］. J Dermatol, 2019,46（3）:276⁃278. doi: 10.1111/1346⁃8138.14768. |
| ［18］ | 刘瑞风, 杨晓红, 梁见楠, 等. 银屑病患者皮损间充质干细胞环状RNA表达异常研究［J］. 中华皮肤科杂志, 2018,51（10）:723⁃728. doi: 10.3760/cma.j.issn.0412⁃4030.2018.10.004. |
| ［19］ | Liu R, Chang W, Li J, et al. Mesenchymal stem cells in psoriatic lesions affect the skin microenvironment through circular RNA［J］. Exp Dermatol, 2019,28（3）:292⁃299. doi: 10.1111/exd.13890. |
| ［20］ | Liu R, Wang Q, Chang W, et al. Characterisation of the circular RNA landscape in mesenchymal stem cells from psoriatic skin lesions［J］. Eur J Dermatol, 2019,29（1）:29⁃38. doi: 10.1684/ejd. 2018.3483. |
| ［21］ | Campanati A, Orciani M, Consales V, et al. Characterization and profiling of immunomodulatory genes in resident mesenchymal stem cells reflect the Th1⁃Th17/Th2 imbalance of psoriasis［J］. Arch Dermatol Res, 2014,306（10）:915⁃920. doi: 10.1007/s00403⁃ 014⁃1493⁃3. |
| ［22］ | Hou R, Yin G, An P, et al. DNA methylation of dermal MSCs in psoriasis: identification of epigenetically dysregulated genes［J］. J Dermatol Sci, 2013,72（2）:103⁃109. doi: 10.1016/j.jdermsci. 2013.07.002. |
| ［23］ | Orciani M, Campanati A, Salvolini E, et al. The mesenchymal stem cell profile in psoriasis［J］. Br J Dermatol, 2011,165（3）:585⁃592. doi: 10.1111/j.1365⁃2133.2011.10438.x. |
| ［24］ | Liu R, Wang Y, Zhao X, et al. Lymphocyte inhibition is compromised in mesenchymal stem cells from psoriatic skin［J］. Eur J Dermatol, 2014,24（5）:560⁃567. doi: 10.1684/ejd.2014. 2394. |
| ［25］ | Chen H, Niu JW, Ning HM, et al. Treatment of psoriasis with mesenchymal stem cells［J］. Am J Med, 2016,129（3）:e13⁃14. doi: 10.1016/j.amjmed.2015.11.001. |
| ［26］ | De Jesus MM, Santiago JS, Trinidad CV, et al. Autologous adipose⁃derived mesenchymal stromal cells for the treatment of psoriasis vulgaris and psoriatic arthritis: a case report［J］. Cell Transplant, 2016,25（11）:2063⁃2069. doi: 10.3727/096368 916X691998. |
| ［27］ | Comella K, Parlo M, Daly R, et al. First⁃in⁃man intravenous implantation of stromal vascular fraction in psoriasis: a case study［J］. Int Med Case Rep J, 2018,11:59⁃64. doi: 10.2147/IMCRJ.S163612. |
| ［28］ | Seetharaman R, Mahmood A, Kshatriya P, et al. Mesenchymal stem cell conditioned media ameliorate psoriasis vulgaris: a case study［J］. Case Rep Dermatol Med, 2019,2019:8309103. doi: 10.1155/2019/8309103. |
| ［29］ | Mendicino M, Bailey AM, Wonnacott K, et al. MSC⁃based product characterization for clinical trials: an FDA perspective［J］. Cell Stem Cell, 2014,14（2）:141⁃145. doi: 10.1016/j.stem. 2014.01.013. |
| ［30］ | Tarte K, Gaillard J, Lataillade JJ, et al. Clinical⁃grade production of human mesenchymal stromal cells: occurrence of aneuploidy without transformation［J］. Blood, 2010,115（8）:1549⁃1553. doi: 10.1182/blood⁃2009⁃05⁃219907. |
| ［31］ | Crowder SW, Horton LW, Lee SH, et al. Passage⁃dependent cancerous transformation of human mesenchymal stem cells under carcinogenic hypoxia［J］. FASEB J, 2013,27（7）:2788⁃2798. doi: 10.1096/fj.13⁃228288. |
| ［32］ | Lazennec G, Lam PY. Recent discoveries concerning the tumor ⁃ mesenchymal stem cell interactions［J］. Biochim Biophys Acta, 2016,1866（2）:290⁃299. doi: 10.1016/j.bbcan.2016.10.004. |
| ［33］ | Jung JW, Kwon M, Choi JC, et al. Familial occurrence of pulmonary embolism after intravenous, adipose tissue⁃derived stem cell therapy［J］. Yonsei Med J, 2013,54（5）:1293⁃1296. doi: 10.3349/ymj.2013.54.5.1293. |
| ［34］ | Furlani D, Ugurlucan M, Ong L, et al. Is the intravascular administration of mesenchymal stem cells safe? Mesenchymal stem cells and intravital microscopy［J］. Microvasc Res, 2009,77（3）:370⁃376. doi: 10.1016/j.mvr.2009.02.001. |
| ［35］ | Xu XM, Luo H, Rong BB, et al. Management of delayed encephalopathy after CO poisoning: an evidence⁃based narrative review［J］. Medicine （Baltimore）, 2019,98（49）:e18199. doi: 10. 1097/MD.0000000000018199. |
| ［36］ | 赵鸣悦, 符粤文, 王倩, 等. 脐血间充质干细胞在难治性重型再生障碍性贫血异基因造血干细胞移植中的应用［J］. 中华血液学杂志, 2019,40（9）:726⁃731. doi: 10.3760/cma.j.issn. 0253⁃2727.2019.09.003. |
| ［37］ | Jayaraj JS, Janapala RN, Qaseem A, et al. Efficacy and safety of stem cell therapy in advanced heart failure patients: a systematic review with a meta⁃analysis of recent trials between 2017 and 2019［J］. Cureus, 2019,11（9）:e5585. doi: 10. 7759/cureus.5585. |
| ［38］ | Zhang Y, Chen W, Feng B, et al. The clinical efficacy and safety of stem cell therapy for diabetes mellitus: a systematic review and meta⁃analysis［J］. Aging Dis, 2020,11（1）:141⁃153. doi: 10.14336/AD.2019.0421. |
| ［39］ | Thompson M, Mei S, Wolfe D, et al. Cell therapy with intravascular administration of mesenchymal stromal cells continues to appear safe: an updated systematic review and meta⁃analysis［J/OL］. E Clinical Medicine, 2020,19:100249［2021⁃03⁃12］. https://www.thelancet.com/journals/eclinm/article/PIIS2589⁃5370(19)30258⁃5/fulltext. doi: 10.1016/ j.eclinm.2019.100249. |
| ［40］ | Gu J, Huang L, Zhang C, et al. Therapeutic evidence of umbilical cord⁃derived mesenchymal stem cell transplantation for cerebral palsy: a randomized, controlled trial［J］. Stem Cell Res Ther, 2020,11（1）:43. doi: 10.1186/s13287⁃019⁃1545⁃x. |
| [1] | 张宁, 李舒, 李敬. 免疫检查点抑制剂和靶向药物辅助治疗可切除黑素瘤疗效的网状Meta分析[J]. 中华皮肤科杂志, 2022, 0(4): 20200767-e20200767. |
| [2] | 李妍, 李明, 徐薇, 李邻峰. [本文开放获取] 丙酸氟替卡松乳膏单独或联合卡泊三醇软膏治疗轻中度斑块状银屑病的随机自身对照研究[J]. 中华皮肤科杂志, 2022, 0(4): 20210246-e20210246. |
| [3] | 王玥, 严煜林. 寻常型银屑病患者171例阿维A治疗相关不良反应及停药原因分析[J]. 中华皮肤科杂志, 2022, 0(2): 20200867-e20200867. |
| [4] | 焦晓燕, 尹光文, 阴亚坤, 李冬芹. 妊娠期、围生期带状疱疹25例临床分析[J]. 中华皮肤科杂志, 2022, 0(2): 20210384-e20210384. |
| [5] | 王佳绮, 王平, 李刘雨, 樊奇敏, 朱蒙燕, 王燕清, 周鸿宇, 沈宏, 许爱娥. 皮肤色素减退性淋巴增殖性疾病41例临床病理分析[J]. 中华皮肤科杂志, 2022, 55(2): 110-115. |
| [6] | 李赛, 薛华忠, 张树文, 蒋娟, 齐淑贞, 赵园园, 张津萍, 沙仲, 乐文静, 王碧伟, 赵诗轩, 朱小凤, 苏晓红. 多西环素-莫西沙星序贯疗法治疗生殖支原体尿道炎/宫颈炎的临床观察[J]. 中华皮肤科杂志, 2022, 0(2): 20210631-e20210631. |
| [7] | 包诗杰, 程杨, 晏莹, 范昉, 高婷婷, 冯小兰, 郑亮, 雷卫, 黄琴斯, 张伟明, 周小勇. 人免疫球蛋白和重组人Ⅱ型肿瘤坏死因子受体-抗体融合蛋白治疗中毒性表皮坏死松解症的对比研究[J]. 中华皮肤科杂志, 2022, 55(2): 153-156. |
| [8] | 欧敏, 颜韵灵, 郑宝庆, 王晓华. 银屑病与肥胖相关性的研究进展[J]. 中华皮肤科杂志, 2022, 55(2): 181-184. |
| [9] | 高蓉 张兰 李政霄. 生物制剂治疗中重度斑块状银屑病及关节病型银屑病的进展[J]. 中华皮肤科杂志, 2022, 55(1): 72-75. |
| [10] | 郭静 杨景煜 丁黎 刘明明 侯晶梅 蒲小霞 孙嘉昱 李向花. 长脉宽1 064 nm Nd：YAG激光联合含滇山茶和三七等提取物的外用乳剂治疗黄褐斑的疗效[J]. 中华皮肤科杂志, 2022, 55(1): 61-64. |
| [11] | 赵莹 王娟娟 季江 苏文星 魏钰倩 冷红 丁瑜洁 施辛. 白细胞介素17A介导银屑病及心血管合并症的研究进展[J]. 中华皮肤科杂志, 2022, 55(1): 76-79. |
| [12] | 中华医学会皮肤性病学分会 中国医师协会皮肤科医师分会. 自身免疫性表皮下大疱病诊疗共识（2022）[J]. 中华皮肤科杂志, 2022, 55(1): 1-11. |
| [13] | 陆佳维, 鲁严. 肿瘤坏死因子α抑制剂及其他生物制剂相关矛盾性银屑病的临床进展[J]. 中华皮肤科杂志, 2022, 0(1): 20210420-e20210420. |
| [14] | 林路洋 陈政良 张锡宝. 寻常型银屑病皮损部位主要免疫相关细胞的研究进展[J]. 中华皮肤科杂志, 2021, 54(9): 830-834. |
| [15] | 邱月棨 付思祺 罗帅寒天 李亚萍 张桂英. 2020年雄激素性脱发的研究进展[J]. 中华皮肤科杂志, 2021, 54(9): 835-838. |
|
